Skip to main content
. 2024 Jun 17;103(9):103986. doi: 10.1016/j.psj.2024.103986

Table 5.

Effect of dietary treatments on concentration of FITC-d on serum and gut morphometry.

Treatments¹
P-value
NC PC V500 V1,000 V1,500 SEM4 ANOVA Linear Quadratic
Conc. of FITC-d at 21 d of age
3Serum (ng/mL) 242 229 244 199 208 0.01 0.632 0.317 0.725
Morphometry
21 d of age
Villus height (µm) 780 762 1,067a 887 806 19.40 <0.001 0.953 0.560
Crypt depth (µm) 228 238 229 219 259 5.97 0.271 0.606 0.374
Villus height: crypt depth 3.5 3.5 4.9a 4.2 3.4 0.12 <0.001 0.841 0.372
42 d of age
Villus height (µm) 1,169 1,24 1,034 1,232 1,209 27.07 0.109 0.860 0.827
Crypt depth (µm) 223 192 201 186 230 5.62 0.054 0.352 0.548
Villus height: crypt depth 5.7 7.0 5.7 6.5 5.7 0.19 0.121 0.399 0.763
1

NC – Control diet, without growth promoter antimicrobials; PC – Control diet, added 0.12g/ton of Enramycin (8%); 500 - Control diet, added 500 g/tonof Viligen; 1,000 - Control diet, added 1,000 g/ton of Viligen; 1,500 - Control diet, added 1,500 g/ton of Viligen.

2Concentration of FITC-d on Serum.

3

SEM = Standard error of the mean.

a

Differs from the positive control treatment by Dunnett's test (P < 0.05).